OpenAI's GPT-Rosalind proposes new leads for drug discovery in neurodegenerative diseases
GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?
AI BriefingOpenAI details new advances in GPT-Rosalind for drug discovery: For the DCTN1 gene associated with Perry syndrome, the model proposed a mechanistic hypothesis based on mouse brain data—that cholesterol may not be transported to where neurons need it—providing a testable direction for treating neurodegenerative diseases.
Reported by 4 other sources
- OpenAI and Scripps Research use thousands of agents to complete a whole-mouse-brain CRISPR atlas analysis in 32 minutesThe Decoder:AI News · 25 days ago
- GPT-Rosalind proposes a new approach to drug development for Perry syndromeGreg Brockman · 26 days ago
- OpenAI uses 1,946 GPT-Rosalind agents to interpret a whole-mouse-brain CRISPR atlas in 32 minutesRohan Paul · 26 days ago
- OpenAI, PerturbAI, and Scripps Research used thousands of GPT-Rosalind agents for 32 minutes to uncover new research leads in brain-cell data.OpenAI: Official Website Updates · 26 days ago
Source: OpenAI · x.com
Event follow-up1
View all event coverage- OpenAI, PerturbAI, and Scripps Research used thousands of GPT-Rosalind agents for 32 minutes to uncover new research leads in brain-cell data.OpenAI: Official Website Updates · 26 days ago